PATENT CLAIM ANALYSIS

Application Number: 15750425
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "139100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 85):
The antibody or antigen binding fragment according to  claim 77 , conjugated to a drug moiety or a detectable moiety.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15229336', '15495048', '15486468', '15521685', '15521434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7768845997083749
- 35 USC 102 Novelty (BERT): 0.6801300665360589
- Combined Prediction Score: 0.7672091463911432
- Mean Citation Score: 532.3024059999998
- Max Citation Score: 948.52997
- Similarity Product: 645.7150679710842

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test